FDA, nilinaw na maaari pa ring gamitin ang Sinovac vaccine para sa healthcare workers

Robie de Guzman   •   February 23, 2021   •   271

MANILA, Philippines – Nilinaw ng Food and Drug Administration (FDA) na maaari pa rin namang gamitin ang Sinovac vaccines sa healthcare workers dahil may maibibigay pa rin naman itong proteksiyon para sa mga hindi exposed o walang contact sa mga pasyenteng may COVID-19.

Ginawa ni FDA Director General Eric Domingo ang paglilinaw matapos nitong ihayag noong Lunes na hindi inirerekomenda sa healthcare workers na exposed sa COVID-19 patients ang Sinovac dahil nasa 50.4% lamang ang efficacy rate nito batay sa resulta ng pagsusuri sa bansang Brazil.

“Recommendation lamang naman yun halimabawa ayaw na niyang hintayin yung ibang bakuna and then willing naman siya to take the vaccine knowing na ang possible efficacy nito sa situation mo is 50% and you’d rather take it now rather than 1 or 2 months from now kung kelan darating yung bakuna pwede naman yun. Hindi naman namin sya ipinagbabawal na gamitin,” ang pahayag ni Domingo.

Paliwanag ni Domingo, bumababa ang bisa ng bakuna kapag madalas na nakakasalamuha ng isang tao ang pasyenteng may COVID-19.

“Ang tao naman kasi iba iba ang situation natin, iba iba rin ang ating suceptibility, saka iba iba yung exposure natin, so depende po yan sa situation. Maaring mas bumaba ang efficacy ng isang vaccine kung tayo ay nasa situation talagang nasa harap natin araw araw yung covid virus, at the exposure is continuous and at high level,” ang paliwanag ng opisyal.

“Maaaring kahit mabakunahan ka ng first dose pero hindi ka pa nakaka-mount ng enough response to ward off yung infection kasi nga masyadong regular iyong exposure sa to the covid-19 virus,” dagdag pa niya.

Binigyang-diin din ng pinuno ng FDA na bagaman naghihintay pa rin na maipalathala ang mga datos ukol sa clinical trial ng Sinovac ay may mga sapat namang batayan para masegurong ligtas itong gamitin.

Posible rin aniyang mapalawak pa ang grupo o edad na pwedeng tumanggap ng naturang bakuna dahil hindi pa tapos ang ginagawa ritong clinical trial.

Tiniyak din ni Domingo na maaari pang marebisa ang mga probisyon sa ibinigay na emergency use authorization ng Pilipinas para sa Sinovac COVID-19 vaccine. – RRD (mula sa ulat ni Correspondent Joan Nano)

DOJ, DILG crafting guidelines for Duterte order to detain people improperly wearing face masks

Robie de Guzman   •   May 6, 2021

MANILA, Philippines – The Department of Justice (DOJ) and the Department of the Interior and Local Government (DILG) are crafting guidelines for the latest order of President Rodrigo Duterte to detain those who are improperly wearing face masks in public, Justice Secretary Menardo Guevarra said Thursday.

In a message to reporters, Guevarra said the guidelines will include details on the booking and detention processes, as well as the investigation and the filing of charges against those who will be apprehended.

The DOJ chief, however, stressed that Duterte’s order takes effect immediately even if the guidelines are still being formulated.

“The President’s directive takes effect immediately even without the guidelines. Existing laws and ordinances define the prohibited acts and impose the corresponding penalties therefore, and the relevant rules of court govern the procedure,” Guevarra said.

He also advised the public to wear face masks properly and to follow the law to avoid being detained.

“The best way to avoid being arrested while the guidelines are being formulated is to wear a face mask and obey the law,” he said.

On Wednesday, Duterte ordered the Philippine National Police to impose a stricter mask mandate to stem the spread of COVID-19 that mostly affected urban centers.

Clinical trials on ivermectin to start in June – DOST

Marje Pelayo   •   May 6, 2021

MANILA, Philippines – Department of Science and Technology (DOST) Secretary Fortunato dela Peña said that preparations are underway for the anticipated clinical trials on the use of ivermectin as a treatment for COVID-19.

In his report to President Rodrigo Duterte on Wednesday (May 5), the official said the trials will be spearheaded by pulmonary doctor Dr. Aileen Wang of the University of the Philippines – Philippine General Hospital (UP-PGH) and will be implemented for eight months from June 2021 to January 2022.

He said the Department of Health (DOH) has allotted a total of P22 million for the trial of ivermectin.

It will be conducted on 1,200 volunteer adults, 18 years old and above, who are asymptomatic or non-severe COVID patients.

The team is awaiting ethics approval this month before proceeding with the trial.

“Ang ginagawa ay ethics approval para sa kanilang gagawin at recruitment ng staff na mag-a-administer ng clinical trials,” Dela Peña said.

They are currently coordinating with the Philippine Red Cross for the utilization of its facilities.

Other agents also under clinical trial are as follows:

* Randomized control clinical trial on the efficacy and safety of Tawa Tawa for adjunctive treatment of mild to moderate COVID-19 patients (11 months);

* Randomized, placebo-controlled trial on the safety and efficacy of Lagundi in patients with mild COVID and without comorbidities (10 months);

* Clinical trial on the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for hospitalized COVID patients (12 months);

* Beneficial effects of VCO among suspect and probable cases of COVID-19 (14 months, extension included);

* Melatonin as adjuvant treatment for COVID-19 in patients requiring hospitalization (9 months) ;

* Convalescent Plasma as adjunctive therapy for hospitalized COVID-19 patients. (12 months).

Dela Peña noted that the duration of clinical trials for ivermectin is almost similar in period as other agents. The progress of each study still depends on the number of patients who want to volunteer for the trial.

“Kapag dumadami ang pasyenteng magbo-volunteer, mas mapapabilis ang pagtatapos ng mga trials,” the official assured.

Quezon Governor Suarez contracts COVID-19

Robie de Guzman   •   May 6, 2021

 

MANILA, Philippines – Quezon Governor Danilo Suarez on Thursday said he has tested positive for novel coronavirus disease (COVID-19).

Suarez made the announcement on the social media account of the Quezon Public Information Office.

The governor said he took an RT-PCR test on May 5 and he received his test result on Thursday morning.

“Sa kasalukuyan, maayos ang aking kalagayan at binabantayan ng aking doktor ang aking kondisyon,” he said.

06 May 2021

Ipinaaabot ko po sa inyong lahat na ang inyong lingkod ay nag-POSITIBO sa COVID-19.

Bilang pag-iingat ay…

Posted by Quezon Public Information Office on Wednesday, May 5, 2021

Suarez urged those who had close interaction with him in the past few days to undergo a self-quarantine and check any symptoms of COVID-19.

“Ipinapaalala ko rin sa inyong lahat na pamalagiang magsuot ng face mask, maghugas ng kamay at sundin ang mga health protocols para sa kaligtasan ng lahat,” he said.

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.